13F HOLDINGS REPORT
Medicxi Ventures Management (Jersey) Ltd
Quarter ended Q2 2024 · Filed July 16, 2024 · Accession 0000950123-24-006607
Total Value
$335.3M
Positions
4
Other Managers
1
Confidential Omitted
No
Holdings (4)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | CENTESSA PHARMACEUTICALS PLC | CNTA | 19,963,157 | $180.3M | 53.77% |
| 2 | PHATHOM PHARMACEUTICALS INC | PHAT | 7,464,572 | $76.9M | 22.93% |
| 3 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 2,869,565 | $55.1M | 16.44% |
| 4 | AURA BIOSCIENCES INC | AURA | 3,039,892 | $23.0M | 6.85% |